Skip to Content
Explore our new website! Designed to better serve patients, partners, and the Crinetics community in the next generation of endocrinology care.

Investigator-Initiated Study Application

Application Requirements

By submitting an application you are not guaranteed the approval of the funding request. Crinetics Pharmaceuticals follows a thorough review process and will approve or deny requests at its sole discretion.

In addition to a completed application, you will need to provide the following with your submission:

  • Letter of request, signed and dated on your organization’s letterhead, that includes the following:
    • Scientific rationale
    • Scope and objective of the study
    • Methodology, including patient selection criteria, study design, sample size justification, dosing (if applicable), and a data analysis plan
    • Data reporting plan
    • Nature and amount of support requested
    • Projected timeline
    • Curriculum Vitae for all investigators
  • W-9 form (US) or W-8 (non-US)
  • IRS tax determination letter (if applicable)
  • If funded, a final study report (publication can be in lieu of study report) must be provided upon completion of study, and Crinetics’ support must be acknowledged in all publications/presentations of study data
  • Funding will not be provided for:
    • Individuals
    • Fellowships
    • Overhead and general operating expenses
    • Entertainment, including meals
    • Awards
    • Travel
  • Before the start of an IIS, an agreement must be complete and fully executed.

Investigator-Initiated Study Application